CEBPA and acute myeloid leukemia: To identify FOXC1 binding sites genome wide and to determine their proximity to RUNX1 and CEBPA binding sites, we performed chromatin immunoprecipitation (ChIP) sequencing (ChIP-seq) for FOXC1, RUNX1, and CEBPA in Fujioka AML cells.